« Back
Lipid Nanoparticles (LNPs) Characterization
Poster Title: Lipid Nanoparticles (LNPs) Characterization
Submitted on 25 Nov 2022
Author(s): Tylor
Poster Views: 105
View poster »

Poster Information
Abstract: They offer promising formulation options for drugs limited by low therapeutic indexes in traditional dosage forms and current "undruggable" targets. Analytical characterization of LNPs is critical to drug design, formulation development, understanding in vivo performance, as well as quality control.Summary: Lipid nanoparticles (LNPs) have shown great success in the pharmaceutical industry, leading to 23 approved products in the U.S. and Europe over the past 30 years. References: Fan Y., et al. Analytical characterization of liposomes and other lipid nanoparticles for drug delivery[J]. Journal of pharmaceutical and biomedical analysis, 2021, 192: 113642.
Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons